Description

Amimestrocel Injection is designed for advanced laboratory research involving cell therapy and immunological studies. Each vial contains 12ml of solution with 6×10^7 biologically active cells, providing a consistent formulation for use in experimental models.

Manufactured by Platinum Excellence Biotech (Beijing) Co., Ltd. and approved by China’s National Medical Products Administration under the number S20250001, Amimestrocel Injection supports research into cell-based immunotherapies, cancer treatment models, and immune system modulation.

This injectable is intended solely for scientific research and is not authorized for human or veterinary use.

Product Specifications

Mechanism of Action & Research Applications

Amimestrocel Injection provides a defined population of cells used for laboratory investigation of immune responses and cell-based therapeutic mechanisms. It is commonly employed in:

• Immunotherapy research and development

• Cancer cell targeting and modeling

• Cellular mechanism studies in oncology and immunology

• Evaluation of cell-based therapy efficacy

• Immune modulation and signaling pathway exploration

This injectable formulation supports researchers in advancing cell therapy science within controlled experimental environments.

Side Effects (For Reference Only in Models)

In experimental settings, Amimestrocel Injection may lead to:

• Immune activation and cytokine production

• Localized inflammation at injection sites

• Changes in cellular viability depending on research protocols

These effects are observed solely within laboratory models and do not indicate clinical outcomes.

Disclaimer

Amimestrocel Injection is strictly intended for laboratory and experimental research use only. It is not designed or approved for human or veterinary therapeutic use. Use under controlled research protocols and safety measures is mandatory.